The clinical response of Venlafaxine for patients with major depression disorder with LDQS and with DBHS:A case-control study

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OPC-15005947

Enrollment

Unknown

Registered

2014-12-24

Start date

2015-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depression Disorder

Interventions

Liver Depression and Qi Stagnation :Venlafaxine

Deficiency of Both Heart and Spleen :Venlafaxine

Control Group :Nil

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. had a diagnosis of major depressive disorder according to DSM-V and TCM criteria of 'pattern of Liver Depression and Qi Stagnation (LDQS)' or 'pattern of Deficiency of Both Heart and Spleen (DBHS)'; 2. The severity of the symptoms is moderate or severe, confirmed by a 35 or greater of HAMD-24 score; 3. Absence of brain and/or severe physical diseases; 4. 18-65years old.

Exclusion criteria

Exclusion criteria: 1. In pregnancy,brain and other severe medical conditions; 2. Psychoactive substance abuse; 3. had a diagnosis of bipolar disorder.

Design outcomes

Primary

Measure	Time frame
hamilton rating scale for depression;	—

Countries

China

Contacts

Public ContactLan-Ying Liu

balindaliu@163.com+86 13516816012

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026